Vertical transmission of human immunodeficiency virus is correlated with the absence of high-affinity/avidity maternal antibodies to the gp120 principal neutralizing domain.
about
A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individualsVertical transmission of human immunodeficiency virus (HIV) infection. Reactivity of maternal sera with glycoprotein 120 and 41 peptides from HIV type 1Maternal plasma viral load and neutralizing/enhancing antibodies in vertical transmission of HIV: a non-randomized prospective studyMixed adjuvant formulations reveal a new combination that elicit antibody response comparable to Freund's adjuvantsFrequent detection of escape from cytotoxic T-lymphocyte recognition in perinatal human immunodeficiency virus (HIV) type 1 transmission: the ariel project for the prevention of transmission of HIV from mother to infant.Common themes of antibody maturation to simian immunodeficiency virus, simian-human immunodeficiency virus, and human immunodeficiency virus type 1 infections.Influence of carbohydrate moieties on the immunogenicity of human immunodeficiency virus type 1 recombinant gp160.Production of site-selected neutralizing human monoclonal antibodies against the third variable domain of the human immunodeficiency virus type 1 envelope glycoprotein.Persistence of multiple maternal genotypes of human immunodeficiency virus type I in infants infected by vertical transmission.Molecular mechanisms of HIV-1 mother-to-child transmission and infection in neonatal target cells.Maternal antibodies enhance or prevent cytomegalovirus infection in the placenta by neonatal Fc receptor-mediated transcytosisPediatric human immunodeficiency virus infection.Safety and efficacy of HIV hyperimmune globulin for prevention of mother-to-child HIV transmission in HIV-1-infected pregnant women and their infants in Kampala, Uganda (HIVIGLOB/NVP STUDY).HIV-I infection in perinatally exposed siblings and twins. The Italian Register for HIV Infection in Children.Genetic analysis of human immunodeficiency virus type 1 envelope V3 region isolates from mothers and infants after perinatal transmission.Analysis of envelope sequence variants suggests multiple mechanisms of mother-to-child transmission of human immunodeficiency virus type 1Characterization of human immunodeficiency virus type 1 p17 matrix protein motifs associated with mother-to-child transmission.The vertical transmission of human immunodeficiency virus type 1: molecular and biological properties of the virus.Human cord blood mononuclear cells are preferentially infected by non-syncytium-inducing, macrophage-tropic human immunodeficiency virus type 1 isolates.Immune response of rhesus macaques to recombinant simian immunodeficiency virus gp130 does not protect from challenge infection.Markers predicting progression of human immunodeficiency virus-related disease.Hybrid human immunodeficiency virus Gag particles as an antigen carrier system: induction of cytotoxic T-cell and humoral responses by a Gag:V3 fusion.Independent variation and positive selection in env V1 and V2 domains within maternal-infant strains of human immunodeficiency virus type 1 in vivoIdentification of the principal neutralizing determinant of human immunodeficiency virus type 1 as a fusion domain.Induction of high-titer neutralizing antibodies, using hybrid human immunodeficiency virus V3-Ty viruslike particles in a clinically relevant adjuvantEngineering Recombinant Reoviruses To Display gp41 Membrane-Proximal External-Region Epitopes from HIV-1Prediction of optimal peptide mixtures to induce broadly neutralizing antibodies to human immunodeficiency virus type 1.Evolution of human immunodeficiency virus type 1 nucleotide sequence diversity among close contacts.Vertical HIV-1 transmission: importance of neutralizing antibody titer and specificity.Cross-protective immune responses induced in rhesus macaques by immunization with attenuated macrophage-tropic simian immunodeficiency virus.Genetic risk factors for perinatally acquired HIV-1 infection.Women and AIDS.AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: detailed analysis of the humoral immune response to a protective vaccinePotential contributions of viral envelope and host genetic factors in a human immunodeficiency virus type 1-infected long-term survivor.Evolution of envelope-specific antibody responses in monkeys experimentally infected or immunized with simian immunodeficiency virus and its association with the development of protective immunity.Mother-to-infant HIV transmission: timing, risk factors and prevention.Prospects for prevention of vertical transmission of human immunodeficiency virus by immunization.Effect of sialic acid removal on the antibody response to the third variable domain of human immunodeficiency virus type-1 envelope glycoprotein.beta 2-Microglobulin and CD4/CD8 ratio as HIV-1 markers of maternal transmissibility, neonatal infection and disease progression.Human immunodeficiency virus type 1 mother-to-child transmission and prevention: successes and controversies.
P2860
Q24560010-A2B93345-9F18-4199-AE61-E630E98B87E7Q24628991-90DF0330-55FC-422B-836A-DB88E7743B43Q24804378-C7D08E36-9F88-4A91-9598-DD5D29F13F5CQ27304735-D5B9BC66-D2BA-41FA-9DCF-91FCAD0F3C9CQ33647187-53CB8A07-F24B-4D73-B444-74587F173B45Q33784692-1DAFACEF-1730-455F-8965-C28C78E9CED5Q33933098-5F0300B2-24EE-4A02-8B69-3BE0E8D65B4DQ34097650-4D41D41A-094F-4B69-8D3D-A760C0E13D04Q34121239-7F0E8D95-4C7E-49D0-96A9-0C22E3CF41BDQ34626428-7C5F61F6-7291-4F9B-9DB2-7B1FC44D9C9CQ35088214-E906A1FA-EB84-4D5D-A82B-5115431BF05FQ35372072-58F2324F-D012-4D3F-AF56-D34FF98F1D74Q35475930-F293BA6F-69ED-4EDE-8C3F-7F2D25FE8268Q35627501-9BBABA2F-EA09-4354-B610-A10DBB453535Q35832182-ADB9E6FD-ABD0-455E-99D9-D6B0A25A8375Q35839969-D972E509-529D-4D61-89CC-7BDDAD9A91D7Q35864074-19883E82-C7BA-4A06-B938-486E0193F8ADQ36033283-7D8FECC4-51B4-46B0-89A3-EADF43983ECEQ36518135-CFE5A1F1-1F4F-4167-979A-BFD3342C0661Q36640342-0014E37D-B1C2-4178-A6DC-4515AF6BD9BFQ36640801-DD942E16-F817-4FCC-A16F-2EE30ABB5962Q36647277-6D03CD1A-FAA0-4885-A776-2D2D76106B3FQ36649929-611DDCA7-8E78-4456-BEF2-E9ADE872E864Q36687883-2B8E69FD-0394-406B-B860-16C260C82907Q36688133-B1AD729C-E0B4-4BA9-88D2-95E1D3858138Q36956100-A248E15D-F683-411B-9FF2-99163FF9C84DQ37567048-84B618B4-AEA7-4926-8B62-754D680283C0Q37643748-227B9D28-6B16-4BD8-9D94-5DAB0032C38AQ38914141-20F1882E-809B-42F3-9848-54ED624ED364Q38948757-B34DB37D-7310-4014-BD66-67BAE4267AEDQ39239480-C8016EBA-9F4A-4916-A18A-34B1D4F16FCFQ39440269-DBCF7283-546D-4A8F-95BB-1AD3881523B5Q39548535-1011DBB6-5354-4F87-9163-245260888051Q39581871-1F70D75E-1C8D-4052-9BD0-E8E12DE0675BQ39880154-1B2865C2-AA10-4404-A29A-54C023A4FE5EQ40510235-E73B0D64-17D0-43DE-992F-6C89A270ACDCQ40793604-37D5F09B-B863-4DF7-959D-49994EA8844EQ44306164-B097658D-391B-4A7E-ACF6-96A3336384ABQ44319274-A0FFAE93-9981-412B-811B-467EF35E4B38Q45363198-EBE23CC7-053C-45B4-A91D-8560088E36B6
P2860
Vertical transmission of human immunodeficiency virus is correlated with the absence of high-affinity/avidity maternal antibodies to the gp120 principal neutralizing domain.
description
1990 nî lūn-bûn
@nan
1990 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Vertical transmission of human ...... principal neutralizing domain.
@ast
Vertical transmission of human ...... principal neutralizing domain.
@en
Vertical transmission of human ...... principal neutralizing domain.
@nl
type
label
Vertical transmission of human ...... principal neutralizing domain.
@ast
Vertical transmission of human ...... principal neutralizing domain.
@en
Vertical transmission of human ...... principal neutralizing domain.
@nl
prefLabel
Vertical transmission of human ...... principal neutralizing domain.
@ast
Vertical transmission of human ...... principal neutralizing domain.
@en
Vertical transmission of human ...... principal neutralizing domain.
@nl
P2093
P2860
P356
P1476
Vertical transmission of human ...... principal neutralizing domain.
@en
P2093
A Rubinstein
K J Reagan
T A Calvelli
P2860
P304
P356
10.1073/PNAS.87.9.3445
P407
P577
1990-05-01T00:00:00Z